Immunotherapy Effective in Alveolar Soft Part Sarcoma


People with advanced alveolar soft part sarcoma (ASPS), a rare cancer, appear to benefit from a type of immunotherapy called an immune checkpoint inhibitor, according to results from a small clinical trial.

Powered by WPeMatico